New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers 29 Oct 2020 A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows. Find out more Show/Hide
Lung cancer in non-smokers likely to respond differently to treatment 09 Jul 2020 Lung cancer in non-smokers is a biologically distinct disease from that in smokers, according to a new study. Researchers also found it has characteristics that mean it could be targeted with tailored treatments. Find out more Show/Hide
AACR Virtual Annual Meeting 2020: Personalised cancer vaccine shows promise in early trial 22 Jun 2020 A personalised cancer vaccine, used in combination with an immunotherapy drug, triggers a response from the immune system that is specific to the cancer and shows some clinical benefit, according to the results of an early clinical trial presented at the virtual AACR conference. Find out more Show/Hide
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy 09 Mar 2019